Prevalence of factor V Leiden mutation in non-European populations

Thromb Haemost. 1997 Feb;77(2):329-31.

Abstract

A difference in the prevalence of venous thromboembolism (TE) in major human groups has been described and an uneven distribution of FV Leiden mutation over the world has recently been reported. We investigated FV Leiden mutation in 584 apparently healthy subjects mostly from populations different from those previously investigated: 170 Europeans (Spanish, Italians), 101 sub-saharan Africans (Fon, Bariba, Berba, Dendi), 115 Asians (Indonesians, Chinese, Tharus), 57 Amerindians (Cayapa), 84 Afroamericans (Rio Cayapa, Viche), and 57 Ethiopians (Amhara, Oromo). The mutation was detected in only 1/115 Asian (Tharu) and in 5/170 Europeans (4 Italians, 1 Spanish). These data confirm that in non-Europeans the prevalence of FV mutation is at least 7 times lower than in Europeans and provide indirect evidence of a low prevalence not only of the FV Leiden gene but also of other genes leading to more severe thrombophilia. Finally, findings from the literature together with those pertaining to this study clearly show a marked heterogeneity among Europeans.

Publication types

  • Comparative Study

MeSH terms

  • Africa South of the Sahara / epidemiology
  • Asia / epidemiology
  • Asian People / genetics
  • Black People / genetics
  • Disease Susceptibility
  • Ethiopia / epidemiology
  • Ethnicity / genetics*
  • Factor V / analysis
  • Factor V / genetics*
  • Gene Frequency
  • Humans
  • Indians, South American / genetics
  • Italy / epidemiology
  • Prevalence
  • Spain / epidemiology
  • Thrombosis / epidemiology*
  • Thrombosis / genetics
  • White People / genetics

Substances

  • factor V Leiden
  • Factor V